Pfizer Announces Positive Late Stage Trial of Cancer Treatment
Pfizer shares were rising Thursday morning.

Pfizer Inc. (PFE) shares were slightly higher in morning trading Thursday after the company announced positive results from its late stage trials of prostate cancer treatment candidate Xtandi. 

The trial was conducted in conjunction with Astellas Pharma Inc. (ALPMF) and found that Xtandi, when combined with a standard prostate cancer therapy, improved survival rates relative to just standard prostate treatments on its own. 

There are currently no FDA-approved treatments for patients with non-metastatic castration-resistant prostate cancer. 

More of What's Trending on TheStreet:

More from Stocks

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker